Posted on

Arcadia Biosciences Rises on Wheat Hype

Just a month ago, Arcadia Biosciences, Inc. (NASDAQ:RKDA) was a penny stock in danger of delisting. But over the past three weeks, the stock has delivered a series of one-day gains as high as 31%. Today, it closed up 34% at $2.62 per share, its highest price since last July. What’s driving the rally? Maybe […]
To access this post, you must purchase a Monthly Subscription or Annual Subscription.
Posted on

Alpha Capital Anstalt

Alpha Capital Anstalt has earned a reputation as one of the world’s most prolific and ruthless investors in cash-starved small-cap companies. Its stock-in-trade are bridge loans and private investments in public equity (PIPE) on terms that are highly unfavorable to desperate issuers. Its favorite instruments are convertible promissory notes, convertible preferred shares, and warrants with anti-dilution provisions and registration rights. As long as issuers remain solvent and honor their agreements, Alpha’s investments typically generate handsome returns for the firm while diluting previous investors, increasing a stock’s float, and putting downward pressure on a stock’s price.

Continue reading Alpha Capital Anstalt

Alpha Capital Anstalt has earned a reputation as one of the world’s most prolific and ruthless investors in cash-starved small-cap companies. Its stock-in-trade are bridge loans and private investments in public equity (PIPE) on terms that are highly unfavorable to desperate issuers. Its favorite instruments are convertible promissory notes, convertible preferred shares, and warrants with anti-dilution provisions and registration rights. As long as issuers remain solvent and honor their agreements, Alpha’s investments typically generate handsome returns for the firm while diluting previous investors, increasing a stock’s float, and putting downward pressure on a stock’s price.

Continue reading Alpha Capital Anstalt